|
| Parameter | Results (%) |
|
| (i) Total number of patients who uses cannabis | 323/383 (84) |
| (ii) No. of patients licensed for MC | 142/323 (44) |
| (iii) No. of patients who consume cannabis without a license | 181/323 (56) |
| (iv) No. of patients who applied for MC license | 317/383 (83) |
| (v) No. of patients who appealed after refusal | 65 |
| (vi) No. of appeals prior to licensing | |
| 1 | 27 |
| 2 | 16 |
| 3 | 10 |
| (vii) No. of licensed patients reporting MC supplied not enough | 94/142 (66) |
| (viii) No. of licensed patients who buy in black market | 78/142 (55) |
| (ix) Amount of cannabis consumed/ month (g) by all the patients | 31.4±16.3, 5-150 |
| (x) Amount of money paid for cannabis in the black market (US$) | 106±206, 29-1428 |
| (xi) Frequency of cannabis consumption/day | 4.7±3.96, 1-20 |
| (xii) No. of patients using ≥ 3 species of MC | 63/142 (~44) |
| (xiii) No. of patients using 2 species of MC | 50/142 (~35) |
| (xiv) No. of patients using 1 species of MC | 29/142 (~21) |
| (xv) Method of cannabis consumption by all participants | |
| Smoking with cigarette | 241/323 (63) |
| Smoking pure cannabis | 85 (~17) |
| Oil under tongue | 18 (~5) |
| Vaporizing | 57 (~15) |
| (xvi) No. of patients reporting adverse effects from cannabis | 36/308 (12) |
| (xvii) No. of patients reporting feeling dependent on cannabis | 25/304 (8) |
| (xviii) No. of patients reporting adverse effects from regular meds for fibromyalgia prior to cannabis use | 336/357 (94) |
| (xix) No. of patients reporting dependence on regular meds | 229/348 (66) |
| (xx) Patients’ report on the use of other meds under cannabis | |
| Using the same other meds | 45/304 (15) |
| Sopped all other meds | 134/304 (44) |
| Consuming less other meds | 125/304 (41) |
|
